1. Home
  2. REXR vs CYTK Comparison

REXR vs CYTK Comparison

Compare REXR & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rexford Industrial Realty Inc.

REXR

Rexford Industrial Realty Inc.

HOLD

Current Price

$41.37

Market Cap

9.7B

Sector

Real Estate

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$65.14

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REXR
CYTK
Founded
2013
1997
Country
United States
United States
Employees
271
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
8.0B
IPO Year
2013
2004

Fundamental Metrics

Financial Performance
Metric
REXR
CYTK
Price
$41.37
$65.14
Analyst Decision
Hold
Strong Buy
Analyst Count
11
15
Target Price
$43.00
$77.87
AVG Volume (30 Days)
1.6M
1.8M
Earning Date
10-15-2025
11-05-2025
Dividend Yield
4.15%
N/A
EPS Growth
15.85
N/A
EPS
1.43
N/A
Revenue
$997,931,000.00
$87,211,000.00
Revenue This Year
$8.07
$363.61
Revenue Next Year
$2.77
$64.33
P/E Ratio
$29.08
N/A
Revenue Growth
10.40
2609.26
52 Week Low
$29.68
$29.31
52 Week High
$44.38
$69.33

Technical Indicators

Market Signals
Indicator
REXR
CYTK
Relative Strength Index (RSI) 52.00 53.37
Support Level $41.09 $62.58
Resistance Level $42.06 $69.33
Average True Range (ATR) 0.84 2.54
MACD 0.08 -0.37
Stochastic Oscillator 66.63 54.91

Price Performance

Historical Comparison
REXR
CYTK

About REXR Rexford Industrial Realty Inc.

Rexford Industrial Realty Inc is a real estate investment trust engaged in owning, operating, and acquiring industrial properties in Southern California infill markets. The goal is to generate attractive risk-adjusted returns for stockholders by providing superior access to industrial property investments in Southern California infill markets. It has one operating segment business of investing in, operating, and repositioning/redeveloping industrial real estate properties located in Southern California infill markets.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: